Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA).

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

[img]
Preview
Text
ADB-CHMINACA_TR_with Annexes and cover.pdf - Published Version

Download (865kB) | Preview

Abstract

In accordance with Article 6 of Council Decision 2005/387/JHA on the information exchange,
risk assessment and control of new psychoactive substances.

Item Type: Other
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Divisions: Pharmacy & Biomolecular Sciences
Publisher: European Monitoring Centre for Drugs and Drug Addiction
Date Deposited: 03 Jan 2018 11:30
Last Modified: 03 Jan 2018 11:30
URI: http://researchonline.ljmu.ac.uk/id/eprint/7766

Actions (login required)

View Item View Item